Immediate Impact

1 by Nobel laureates 1 from Science/Nature 42 standout
Sub-graph 1 of 21

Citing Papers

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
2024 Standout
1 intermediate paper

Works of Daniel Glick being referenced

Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non–Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis
2018

Author Peers

Author Last Decade Papers Cites
Daniel Glick 221 88 95 15 332
C.S. Boon 63 50 123 18 292
Francisco Lozano‐Ruíz 178 41 65 11 283
Wendy Munoz-Moñtano 188 39 125 20 365
Michael D. Bastasch 170 146 34 15 302
Marisol Arroyo‐Hernández 201 43 113 11 329
J. Marruecos 134 31 95 21 280
Marco Perna 175 30 114 19 292
Elisa Dieci 222 35 31 16 312
Young-Pil Wang 204 22 50 16 334
Alberto Gramaglia 96 36 54 20 264

All Works

Loading papers...

Rankless by CCL
2026